Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Instituto do Cancer do Estado de São Paulo
AHS Cancer Control Alberta
AIDS Malignancy Consortium
AIDS Malignancy Consortium
Tata Memorial Centre
Centre Hospitalier Universitaire de Besancon
University of Sao Paulo
Sun Yat-sen University
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Centre Hospitalier Universitaire de Besancon
Sixth Affiliated Hospital, Sun Yat-sen University
UNICANCER
Centre Hospitalier Universitaire de Besancon
Sixth Affiliated Hospital, Sun Yat-sen University
Radiation Therapy Oncology Group
AHS Cancer Control Alberta
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)